Two patients undergoing liver transplantation for classical end-stage primary biliary cirrhosis (PBC) are described, who went on to develop de novo autoimmune hepatitis (AIH) in the transplanted liver. The presentation, in both instances, was with malaise and lethargy. Markedly elevated serum transa
Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry
✍ Scribed by Christoph Schramm; Michael Bubenheim; René Adam; Vincent Karam; John Buckels; John G. O'Grady; Neville Jamieson; Stephen Pollard; Peter Neuhaus; Michael M. Manns; Robert Porte; Denis Castaing; Andreas Paul; Oscar Traynor; James Garden; Styrbjörn Friman; Bo-Goran Ericzon; Lutz Fischer; Stefan Vitko; Marek Krawczyk; Herold J. Metselaar; Aksel Foss; Murat Kilic; Keith Rolles; Patrizia Burra; Xavier Rogiers; Ansgar W. Lohse
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 366 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22018
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Our center has attempted to minimize corticosteroid (CS) use in all of our orthotopic liver transplantation (OLT) recipients. Because patients with autoimmune hepatitis (AIH) typically require CSs after transplantation, we reviewed our experience in this cohort of patients to determine (1) patient o
Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging
Improved outcome after liver transplantation (LTX) for hepatocellular carcinoma (HCC) made LTX a legitimate treatment of the disease. We analyzed trends of LTX for HCC with tumors known before transplantation in 902 patients in a large international registry across 3 periods: 1983-1990, 1991-1996, a
Several treatment options exist for the management of Budd-Chiari syndrome (BCS), yet the relative role and timing of liver transplantation (LT) remain poorly defined. Small case series published to date have not been able to delineate the impact of comorbidities and thromboembolic complications of
Hepatic sarcoidosis is a rare indication for liver transplantation. Using the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) database, we evaluated patient and graft survival after orthotopic liver transplantation for sarcoidosis between October 1987 and